Utama › Gangguan Neuromuskular › California
Kajian klinikal Gangguan Neuromuskular di California
6 kajian untuk Gangguan Neuromuskular sedang mencari peserta di lokasi di California.
Teks kajian rasmi (Bahasa Inggeris)
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, La Jolla
- Research Site, Sacramento
Mengambil pesertaFasa 1
Umur 18 hingga 70 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06916806A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
- University of California, Irvine (UCI), Irvine
- Stanford Neuroscience Health Center, Palo Alto
Mengambil pesertaFasa 1/2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 20 Jul 2026 · NCT07282847Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
- University of California, Davis, Sacramento
Mengambil peserta
Umur 22 hingga 75 · Semua jantina · Dikemas kini 14 Apr 2026 · NCT07357428Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
- Stanford University, Palo Alto
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 5 ke atas · Semua jantina · Dikemas kini 9 Apr 2026 · NCT06839469Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Apr 2022 · NCT04684602Congenital Muscle Disease Study of Patient and Family Reported Medical Information
- Congenital Muscle Disease International Registry (www.cmdir.org), Lakewood
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 9 Ogo 2021 · NCT01403402Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.